Literature DB >> 22963010

Low luminance visual acuity in patients with central serous chorioretinopathy.

Kyoko Fujita1, Kei Shinoda, Celso Soiti Matsumoto, Yutaka Imamura, Yoshihiro Mizutani, Etsuko Tanaka, Atsushi Mizota, Koichi Oda, Mitsuko Yuzawa.   

Abstract

BACKGROUND: The aim was to determine the low luminance visual acuity in eyes with central serous chorioretinopathy.
METHODS: Seven eyes of seven patients with central serous chorioretinopathy and six eyes of six age-matched normal volunteers were examined. Low luminance visual acuity charts were created by an Apple Power Mac G5 computer and displayed on a cathode ray tube monitor (SONY GDM-F500). The background luminance was set at six different levels from 78.20 cd/m(2) to 0.37 cd/m(2). The visual acuities of the eyes with central serous chorioretinopathy at each of the six luminance levels were compared to those from their fellow eyes and to normal eyes.
RESULTS: The mean visual acuities varied from 0.13, 0.23, 0.29, 0.42, 0.62 to 0.70 logMAR units as luminance varied from high to low. At the lowest luminance (0.37 cd/m(2)), five of the seven eyes could not read any character. The mean visual acuities of the fellow eyes at the same luminance levels were 0.03, 0.06, 0.11, 0.20, 0.27 and 0.45 logMAR units and those of the normal volunteers were 0, 0.03, 0.08, 0.14, 0.23 and 0.38 logMAR units, respectively. The visual acuities of the eyes with central serous chorioretinopathy were significantly poorer than those of the normal eyes at all luminance levels except 0.37 cd/m(2) (p < 0.05 for all).
CONCLUSIONS: Although the eyes from all three groups had 0 logMAR units visual acuity under standard testing condition, the visual acuity of the eyes with central serous chorioretinopathy were significantly worse at low luminance levels. The low luminance visual acuity may provide information on the visual disturbances reported by central serous chorioretinopathy patients with 0 logMAR units visual acuity.
© 2012 The Authors. Clinical and Experimental Optometry © 2012 Optometrists Association Australia.

Entities:  

Mesh:

Year:  2012        PMID: 22963010     DOI: 10.1111/j.1444-0938.2012.00796.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  6 in total

1.  Repeatability of mesopic visual acuity measurements using high- and low-contrast ETDRS letter charts.

Authors:  Ana Barrio; Beatriz Antona; María C Puell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-09       Impact factor: 3.117

2.  Mesopic visual acuity is less crowded.

Authors:  František Pluháček; John Siderov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-28       Impact factor: 3.117

3.  Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy.

Authors:  Eleni Karatsai; Piyali Sen; Sarega Gurudas; Sobha Sivaprasad
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

4.  Detecting Progression of Retinitis Pigmentosa Using the Binomial Pointwise Linear Regression Method.

Authors:  Shotaro Asano; Akio Oishi; Ryo Asaoka; Yuri Fujino; Hiroshi Murata; Keiko Azuma; Manabu Miyata; Ryo Obata; Tatsuya Inoue
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

5.  Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.

Authors:  Atalie C Thompson; Ulrich F O Luhmann; Sandra S Stinnett; Lejla Vajzovic; Anupama Horne; Cynthia A Toth; Scott W Cousins; Eleonora M Lad
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

6.  Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity.

Authors:  Aya Chubachi; Akiko Miki; Mayuka Hayashida; Mari Sakamoto; Hisanori Imai; Sentaro Kusuhara; Makoto Nakamura
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.